Augustine Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$84.2M

Augustine Therapeutics is a biotechnology company developing therapies for neuromuscular, neurodegenerative, and cardio-metabolic diseases through selective inhibition of the HDAC6 enzyme.